Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

Add To Watchlist

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Well tolerated by cohort #5...

View:

Post by BottomBroker on Oct 30, 2024 9:40am

Well tolerated by cohort #5...

So we can put that one to rest.

Comment

Comment by Gbathat on Oct 30, 2024 7:37pm

It was also in Neil's last presentation, yet those griping about it incessantly around here refused to listen and continued spewing their despicable lies. PMN will rise. Phase 1b (winter) is coming.

105

Comment

Comment by FarmerBetsy on Oct 30, 2024 10:33pm

Yes Elliott not sure what your point is ? Found this interesting, PMN310 concentrations were collected before, and at the end of the infusion and at 0.5, 1, 2, 4, 8, 12, 24, 36, 72, 192 hours and approximately biweekly after infusion. CSF collection was done at day 3 and day 29 after dosing to determine CSF concentration of PMN310. For more information on the Phase 1a, Double ...more

127

Comment

ProMIS Neurosciences Inc